Oncofetal fibronectin mRNA is highly abundant in the blood of patients with papillary thyroid carcinoma and correlates with high-serum thyroid-stimulating hormone levels.

  • Michael Wehmeier
  • Thorsten Petrich
  • Korbinian Brand
  • Ralf Lichtinghagen
  • Eric Hesse

Abstract

Papillary thyroid carcinoma (PTC) cells express oncofetal fibronectin (onfFN) mRNA, which may be useful to detect circulating tumor cells. The objective of this study was to determine the fraction of PTC patients having onfFN mRNA in their peripheral blood and to determine if onfFN mRNA levels are correlated with the status of the disease or with thyroid-stimulating hormone (TSH) serum concentrations.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer6
ISSN1050-7256
StatusVeröffentlicht - 2010
pubmed 20470202